305
Views
14
CrossRef citations to date
0
Altmetric
Original Articles: Clinical

Utility of interim and end-of-treatment [18F]-fluorodeoxyglucose positron emission tomography–computed tomography in frontline therapy of patients with diffuse large B-cell lymphoma

, , , &
Pages 2579-2584 | Received 29 Oct 2014, Accepted 08 Jan 2015, Published online: 11 Feb 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Jihyun Kim, Yoo Sung Song, Jong Seok Lee, Won Woo Lee & Sang Eun Kim. (2018) Risk stratification of diffuse large B-cell lymphoma with interim PET-CT based on different cutoff Deauville scores. Leukemia & Lymphoma 59:2, pages 340-347.
Read now

Articles from other publishers (13)

Jia Jin, Dongmei Ji, Zuguang Xia, Kai Xue, Qunling Zhang, Yizhen Liu, Junning Cao, Xiaonan Hong, Juan J. Gu, Ye Guo & Fangfang Lv. (2022) Four cycles of R-CHOP followed by two applications of rituximab based on negative interim PET/CT: an analysis of a prospective trial. BMC Cancer 22:1.
Crossref
Ciara L. Freeman, Kerry J. Savage, Diego R. Villa, David W. ScottLine Srour, Alina S. Gerrie, Maura J. BrownGraham W. SlackPedro Farinha, Brian SkinniderJames Morris, François Bénard, Christina Aquino-Parsons, Andrea Lo, Tom Pickles, Don C. Wilson, Petter Tonseth, Joseph M. Connors & Laurie H. Sehn. (2021) Long-term results of PET-guided radiation in patients with advanced-stage diffuse large B-cell lymphoma treated with R-CHOP. Blood 137:7, pages 929-938.
Crossref
Sally F Barrington & Judith Trotman. (2021) The role of PET in the first-line treatment of the most common subtypes of non-Hodgkin lymphoma. The Lancet Haematology 8:1, pages e80-e93.
Crossref
Jia Jin, Yizhen Liu, Qunling Zhang, Kai Xue, Zuguang Xia, Junning Cao, Xiaonan Hong, Ye Guo & Fangfang Lv. (2020) Interim PET/CT result is the sole prognostic factor of survival in patients with advanced-stage diffuse large B-cell lymphoma: a subset analysis of a prospective trial. Journal of Radioanalytical and Nuclear Chemistry 327:1, pages 353-358.
Crossref
Arihant Jain, Ankur Jain & Pankaj Malhotra. (2019) Re-defining Prognosis of Hematological Malignancies by Dynamic Response Assessment Methods: Lessons Learnt in Chronic Myeloid Leukemia, Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma and Multiple Myeloma. Indian Journal of Hematology and Blood Transfusion 36:3, pages 447-457.
Crossref
Bouthaina Shbib Dabaja. (2018) Successful role of radiation therapy: Account for every single gray and make every single gray count. Best Practice & Research Clinical Haematology 31:3, pages 217-232.
Crossref
A. Besson, C. Baillet, C. Herbaux, C. Foucher, A. Lambilliotte, F. Morschhauser & D. Huglo. (2018) Variabilité des SUV et SUL hépatiques dans le suivi des lymphomes avides de FDG en cours de chimiothérapie. Médecine Nucléaire 42:2, pages 114-124.
Crossref
Sally F. Barrington & Kent Friedman. 2018. PET/MRI in Oncology. PET/MRI in Oncology 373 400 .
Yu Chang, Xiaorui Fu, Zhenchang Sun, Xinli Xie, Ruihua Wang, Zhaoming Li, Xudong Zhang, Guangyao Sheng & Mingzhi Zhang. (2017) Utility of baseline, interim and end-of-treatment 18F-FDG PET/CT in extranodal natural killer/T-cell lymphoma patients treated with L-asparaginase/pegaspargase. Scientific Reports 7:1.
Crossref
Wolfgang Luboldt, Baerbel Wiedemann, Sebastian Fischer, Boris Bodelle, Hans Joachim Luboldt, Frank Grünwald & Thomas J. Vogl. (2016) Focal colorectal uptake in 18FDG-PET/CT: maximum standard uptake value as a trigger in a semi-automated screening setting. European Journal of Medical Research 21:1.
Crossref
Maital Bolshinsky & Chadi Nabhan. (2016) Interim PET Scans in Diffuse Large B-Cell Lymphoma: Is It Ready for Prime Time?. Clinical Lymphoma Myeloma and Leukemia 16:12, pages 655-661.
Crossref
Sally F. Barrington & N. George Mikhaeel. (2016) PET Scans for Staging and Restaging in Diffuse Large B-Cell and Follicular Lymphomas. Current Hematologic Malignancy Reports 11:3, pages 185-195.
Crossref
Ashley D Staton, Jean L Koff, Qiushi Chen, Turgay Ayer & Christopher R Flowers. (2015) Next-generation prognostic assessment for diffuse large B-cell lymphoma. Future Oncology 11:17, pages 2443-2457.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.